TERAZOL 3 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Terazol 3, and when can generic versions of Terazol 3 launch?
Terazol 3 is a drug marketed by Janssen Pharms and is included in two NDAs.
The generic ingredient in TERAZOL 3 is terconazole. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the terconazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Terazol 3
A generic version of TERAZOL 3 was approved as terconazole by TARO on April 6th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TERAZOL 3?
- What are the global sales for TERAZOL 3?
- What is Average Wholesale Price for TERAZOL 3?
Summary for TERAZOL 3
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Patent Applications: | 5,161 |
DailyMed Link: | TERAZOL 3 at DailyMed |
US Patents and Regulatory Information for TERAZOL 3
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | TERAZOL 3 | terconazole | CREAM;VAGINAL | 019964-001 | Feb 21, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Janssen Pharms | TERAZOL 3 | terconazole | SUPPOSITORY;VAGINAL | 019641-001 | May 24, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TERAZOL 3
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | TERAZOL 3 | terconazole | CREAM;VAGINAL | 019964-001 | Feb 21, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | TERAZOL 3 | terconazole | SUPPOSITORY;VAGINAL | 019641-001 | May 24, 1988 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TERAZOL 3
See the table below for patents covering TERAZOL 3 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 465981 | ⤷ Sign Up | |
Kenya | 3270 | 1-(1,3-DIOXOLAN-2-YLMETHYL)-1H-IMIDAZOLES AND 1H-1,2,4-TRIAZOLES | ⤷ Sign Up |
Malaysia | 8400209 | 1-(1,3-DIOXLAN-2-YLMETHYL)-H-IMIDAZOLES AND 1H-1,2.4-TRIAZOLES | ⤷ Sign Up |
Hungary | 177646 | PROCESS FOR PRODUCING NEW 1-BRACKET-1,3-DIOXOLANE-2-YL-METHYL-BRACKET CLOSED-1H-IMIDASOLE DERIVATIVES | ⤷ Sign Up |
Netherlands | 7801048 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |